|
|
||||||||||
|
J Am Coll Cardiol, 1990; 16:1481-1491 © 1990 by the American College of Cardiology Foundation |
Division of Cardiology, Georgetown University Medical Center, Washington, D.C.
This study investigated the effect of intravenous cocaine (0.5 to 2 mg/kg body weight) on the coronary circulation and systemic hemodynamics in closed chest sedated dogs. The role of alpha- and beta-adrenoceptor stimulation in mediating these effects was also investigated. Cocaine produced dose-dependent increases in mean arterial pressure and rate-pressure product. Although the lower doses of cocaine had no significant effect on the coronary circulation, the 2 mg/kg dose produced a 55 +/- 14% increase in coronary vascular resistance (p less than 0.05 versus baseline) and a 19 +/- 3% reduction in diameter of the left anterior descending coronary artery (p less than 0.05 versus baseline). Despite these potentially deleterious effects on the coronary circulation (occurring at a time of markedly increased myocardial oxygen demand), the electrocardiogram did not demonstrate ischemic changes and there was no myocardial lactate production. Cocaine-induced coronary vasoconstriction was abolished by pretreatment with the alpha-adrenoceptor antagonist phentolamine, but not by pretreatment with the beta-adrenoceptor antagonist propranolol. The findings that cocaine did not change systemic vascular resistance in dogs without adrenergic blockade, reduced systemic vascular resistance in dogs after alpha-blockade (p less than 0.05) and increased systemic vascular resistance in dogs after beta-blockade (p = 0.06) suggest that epinephrine (rather than norepinephrine) is primarily responsible for the peripheral vascular actions of cocaine. Thus, in this canine preparation with normal coronary arteries, cocaine produced vasoconstriction of both epicardial and coronary resistance vessels that was not associated with evidence of myocardial ischemia. The pharmacologic mechanism for the effect of cocaine on the coronary circulation is alpha-adrenoceptor stimulation, whereas systemic hemodynamic effects are mediated by combined alpha- and beta-adrenoceptor stimulation.
This article has been cited by other articles:
![]() |
M. Isabelle, C. Monteil, F. Moritz, B. Dautreaux, J.-P. Henry, V. Richard, P. Mulder, and C. Thuillez Role of {alpha}1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction Cardiovasc Res, September 1, 2005; 67(4): 699 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Schindler, J. P. Gilman, J. Bergman, N. K. Mello, R. L. Woosley, and S. R. Goldberg Interactions between Cocaine and Dopamine Agonists on Cardiovascular Function in Squirrel Monkeys J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 180 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Shannon, M. A. Mathier, and Y.-T. Shen Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1347 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Shannon, P. Lozano, Q. Cai, W. T. Manders, and Y.-t. Shen Mechanism of the Systemic, Left Ventricular, and Coronary Vascular Tolerance to a Binge of Cocaine in Conscious Dogs Circulation, August 1, 1996; 94(3): 534 - 541. [Abstract] [Full Text] |
||||
![]() |
R. P. Shannon, W. T. Manders, and Y.-T. Shen Role of Blood Doping in the Coronary Vasoconstrictor Response to Cocaine Circulation, July 1, 1995; 92(1): 96 - 105. [Abstract] [Full Text] |
||||
![]() |
D. J. Moliterno, J. E. Willard, R. A. Lange, B. H. Negus, J. D. Boehrer, D. B. Glamann, C. Landau, J. D. Rossen, M. D. Winniford, and L. D. Hillis Coronary-Artery Vasoconstriction Induced by Cocaine, Cigarette Smoking, or Both N. Engl. J. Med., February 17, 1994; 330(7): 454 - 459. [Abstract] [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |